The F/m Emerald Life Sciences Innovation ETF (LFSC) has 40 holdings, with Corcept Therapeutics, LivaNova, and Travere Therapeutics among its largest positions. The top 25 LFSC holdings ordered by weight make up 90.22% of the total fund. LFSC is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete LFSC stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.
Top 25 LFSC Holdings
LFSC Geographic Exposure
LFSC's largest geographic exposure is United States at 91.6%, followed by United Kingdom at 7.1%.
LFSC Currency Exposure
LFSC is exclusively exposed to USD.
LFSC Sector Exposure
LFSC's largest sector exposure is Health Care at 82.2%, followed by Consumer Discretionary at 5.4%.
LFSC Industry Exposure
LFSC's largest industry exposure is Biotechnology at 57.2%, followed by Health Care Equipment & Supplies at 19.3%.
Health Care Equipment & Supplies
Diversified Consumer Services
Health Care Providers & Services
LFSC Sub-Industry Exposure
LFSC's largest sub-industry exposure is Biotechnology at 54.0%, followed by Health Care Equipment at 18.2%.
Life Sciences Tools & Services
Free LFSC Stock Alerts